A Look At Viatris (VTRS) Valuation After Recent Regulatory And Pipeline Milestones [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
acetate injectable and progress on contraceptive, gene therapy, and sleep-disorder treatments. See our latest analysis for Viatris. These pipeline updates arrive as Viatris shares trade at $12.46, with a 30 day share price return of 14.0% and a 90 day share price return of 22.88%, while the 1 year total shareholder return is 9.57% and the 3 year total shareholder return is 19.04%, suggesting recent momentum has been building after a weaker 5 year total shareholder return of 17.47%. If this kind of pipeline progress has caught your eye, it could be worth widening your lens to other healthcare stocks that are moving on clinical or regulatory catalysts. So with Viatris trading around $12.46, showing double digit gains over the past 30 and 90 days but a weaker 5-year total shareholder return, is the market still underrating the pipeline or already pricing in future growth? The most followed narrative sees Viatris fairly close to its assessed value, with a fair value of US$12.44
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer [Yahoo! Finance]Yahoo! Finance
- Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs OfficerPR Newswire
- Assessing Idorsia (SWX:IDIA) Valuation After Recent Share Price Swings And Pipeline Developments [Yahoo! Finance]Yahoo! Finance
- Viatris Inc. (VTRS) Provides Updates on Four Recent Regulatory Milestones [Yahoo! Finance]Yahoo! Finance
- 1 Momentum Stock to Target This Week and 2 That Underwhelm [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 11/6/25 - Beat
VTRS
Sec Filings
- 1/2/26 - Form 4
- 12/8/25 - Form 8-K
- 12/5/25 - Form 8-K
- VTRS's page on the SEC website